BSX, AET, BAX, MDT And UNH, Pushing Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 126 points (-0.8%) at 15,723 as of Friday, Jan. 31, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,087 issues advancing vs. 1,837 declining with 186 unchanged.

The Health Services industry currently sits down 0.7% versus the S&P 500, which is down 0.5%. On the negative front, top decliners within the industry include Hanger ( HGR), down 14.3%, C.R. Bard ( BCR), down 2.5%, Intuitive Surgical ( ISRG), down 1.6%, CareFusion ( CFN), down 1.5% and Fresenius Medical Care AG & Co. KGaA ( FMS), down 1.5%. A company within the industry that increased today was HCA Holdings ( HCA), up 1.2%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. Boston Scientific ( BSX) is one of the companies pushing the Health Services industry lower today. As of noon trading, Boston Scientific is down $0.11 (-0.8%) to $13.45 on light volume. Thus far, 3.7 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 10.9 million shares. The stock has ranged in price between $13.30-$13.47 after having opened the day at $13.40 as compared to the previous trading day's close of $13.56.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $17.6 billion and is part of the health care sector. Shares are up 9.7% year-to-date as of the close of trading on Thursday. Currently there are 7 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates Boston Scientific as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and compelling growth in net income. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full Boston Scientific Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

4. As of noon trading, Aetna ( AET) is down $0.43 (-0.6%) to $68.42 on light volume. Thus far, 918,116 shares of Aetna exchanged hands as compared to its average daily volume of 2.5 million shares. The stock has ranged in price between $67.98-$68.51 after having opened the day at $68.18 as compared to the previous trading day's close of $68.85.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $25.0 billion and is part of the health care sector. The company has a P/E ratio of 13.8, below the S&P 500 P/E ratio of 17.7. Shares are up 0.4% year-to-date as of the close of trading on Thursday. Currently there are 11 analysts that rate Aetna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, attractive valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Aetna Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

3. As of noon trading, Baxter International ( BAX) is down $0.83 (-1.2%) to $68.44 on light volume. Thus far, 1.1 million shares of Baxter International exchanged hands as compared to its average daily volume of 3.4 million shares. The stock has ranged in price between $68.36-$68.69 after having opened the day at $68.62 as compared to the previous trading day's close of $69.27.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $37.1 billion and is part of the health care sector. The company has a P/E ratio of 14.7, below the S&P 500 P/E ratio of 17.7. Shares are down 0.4% year-to-date as of the close of trading on Thursday. Currently there are 5 analysts that rate Baxter International a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Baxter International Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Medtronic ( MDT) is down $0.52 (-0.9%) to $56.50 on light volume. Thus far, 1.3 million shares of Medtronic exchanged hands as compared to its average daily volume of 4.4 million shares. The stock has ranged in price between $56.11-$56.78 after having opened the day at $56.40 as compared to the previous trading day's close of $57.01.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $56.3 billion and is part of the health care sector. The company has a P/E ratio of 15.1, below the S&P 500 P/E ratio of 17.7. Shares are down 0.7% year-to-date as of the close of trading on Thursday. Currently there are 8 analysts that rate Medtronic a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and notable return on equity. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Medtronic Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, UnitedHealth Group ( UNH) is down $0.76 (-1.0%) to $72.04 on light volume. Thus far, 1.0 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 4.5 million shares. The stock has ranged in price between $71.45-$72.32 after having opened the day at $71.87 as compared to the previous trading day's close of $72.80.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $71.7 billion and is part of the health care sector. The company has a P/E ratio of 13.0, below the S&P 500 P/E ratio of 17.7. Shares are down 3.3% year-to-date as of the close of trading on Thursday. Currently there are 14 analysts that rate UnitedHealth Group a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, attractive valuation levels and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full UnitedHealth Group Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Facebook, Amazon, Microsoft and Ford - 5 Things You Must Know

Facebook, Amazon, Microsoft and Ford - 5 Things You Must Know

Facebook Set for Biggest Gain in Two Years After Q1 Earnings Top Forecasts

Facebook Set for Biggest Gain in Two Years After Q1 Earnings Top Forecasts

Global Stocks Mixed, U.S. Futures Soften as Earnings, Oil, Rates Cloud Sentiment

Global Stocks Mixed, U.S. Futures Soften as Earnings, Oil, Rates Cloud Sentiment

European Automakers Gain on Reports China Mulling Auto Tariff Reduction

European Automakers Gain on Reports China Mulling Auto Tariff Reduction

Deutsche Bank Plans 'Significant' Job Cuts as Q1 Profits Slump

Deutsche Bank Plans 'Significant' Job Cuts as Q1 Profits Slump